Results 111 to 120 of about 8,134 (274)
CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN
SUMMARY BCG adverse events (BCG-AE) are rare conditions with no well-established treatment. This study aims to describe clinical characteristics and outcome of localized BCG-AE.
Thais das Neves Fraga Moreira +4 more
semanticscholar +1 more source
Evaluation of the impact of the COVID-19 pandemic on patients with psoriasis using immunobiologicals
Objective: Psoriasis is a systemic inflammatory and immune-mediated disease. The treatment of this condition with immunobiologicals has shown excellent responses, however, one of the known adverse effects is susceptibility to infections due to ...
Maiara C. Macagnan +3 more
doaj
Background: Histoplasmosis is the second most frequent granulomatous disease in patients treated with tumor necrosis factor (TNF)-α inhibitors, second only to tuberculosis.
Murillo M. Cipolat +8 more
semanticscholar +1 more source
The emergence of SARS-CoV-2, leading to the widespread outbreak of COVID-19, has unveiled a spectrum of symptoms and severe health complications, challenging healthcare systems and impacting millions of lives worldwide.
Matheus Sallys Oliveira Silva +9 more
semanticscholar +1 more source
The Journal of Pathology: Clinical Research, Volume 11, Issue 6, November 2025.
DuJiang Yang, Jiexiang Yang, GuoYou Wang
wiley +1 more source
P3–274: Immunobiological markers in Alzheimer's disease [PDF]
Konstantinos Bonotis +1 more
openalex +1 more source
Hyperimmune globulin and monoclonal antibody for the treatment of SARS CoV-2 infection [PDF]
The current pandemic of COVID-19 (Coronavirus Disease-19), caused by the pathogen SARSCoV-2, leading to thousands of deaths in 2020, has mobilized the scientific community, with the purpose of understanding the different aspects of the disease and ...
Almeida de Oliveira, Leandro +5 more
core +1 more source
Psoriasis in moderate grave plaque - immunobiological treatment [PDF]
Marcelo Arnone +3 more
openalex +1 more source
Situation of immunobiological vaccine coverage in the period from 2009-2014
Aim: to check the status of vaccination coverage in the three political and administrative levels in the period from 2009-2014. Method: historical series study.
Taís Trombetta Dalla Nora +4 more
doaj +1 more source

